Managing HHH Syndrome Day-to-Day
At a Glance
Managing HHH syndrome requires an individualized, calorie-sufficient low-protein diet, selected amino acid supplements, and ammonia-scavenger medicines when needed. Regular blood tests, growth checks, liver monitoring, and a written sick-day plan help prevent dangerous ammonia increases.
Managing HHH syndrome is a lifelong balancing act. The goal of treatment is to keep toxic ammonia levels low while providing enough nutrition for the body to grow and function [1][2]. This is achieved through a combination of a specialized diet, amino acid supplements, and medications that “scavenge” ammonia from the blood [1].
Important Safety Warning: All treatments discussed here must be strictly directed by your metabolic team. Never start, stop, or change the dose of formula, supplements, or scavengers on your own. There is no single universal target for ammonia or protein; your targets are individualized based on age, growth, labs, and residual enzyme function.
The Foundation: A Eucaloric, Low-Protein Diet
The most important part of your treatment is a eucaloric, low-protein diet. “Eucaloric” means you must eat enough total calories to meet your body’s energy needs [2]. If you do not eat enough calories, your body will begin to break down its own muscle for fuel (a state called catabolism), which releases a massive amount of ammonia into your system [3].
- Natural Protein Restriction: You will work with a specialized metabolic dietitian to determine exactly how many grams of “natural” protein (from regular food) you can safely eat [4].
- Precision for Growth: It is a common mistake to think the goal is “zero” protein. In fact, eating too little protein can stunt growth. In children with urea cycle disorders, height is directly linked to the ratio of natural protein to total energy intake [5].
- Metabolic Formula: To make up for the protein you can’t eat from food, you may be prescribed a specialized formula. While all amino acids contain nitrogen, the purpose of a UCD formula is to provide essential amino acids and micronutrients while tightly controlling total nitrogen and maintaining growth [2][6].
Amino Acid Supplementation
Because the “shuttle” (ORNT1) is impaired in HHH syndrome, your body cannot properly move the ingredients needed for the urea cycle. To fix this, doctors use supplements to “bypass” the traffic jam. These are highly individualized interventions based on plasma amino acids and age; unnecessary supplements add dangerous nitrogen and may be harmful.
- L-Citrulline vs. L-Arginine: Both of these amino acids help the urea cycle run. While both are used, some research suggests that L-citrulline may be more effective at raising blood arginine levels in HHH patients than taking arginine itself, though this depends entirely on your specialist’s protocol [6][1].
- Lysine: HHH is unique because the “shuttle” that is broken also helps move lysine. Some patients benefit from lysine supplementation, as it can be low in people with HHH [7][1].
- BCAAs: Supplements of branched-chain amino acids (leucine, isoleucine, and valine) may be used to ensure your levels stay normal, which is critical for protecting the brain and supporting growth [6][5].
Ammonia Scavengers: “The Backup Plan”
When diet and supplements aren’t enough to keep ammonia in a safe range, doctors prescribe nitrogen scavengers. These medications provide alternate nitrogen-excretion pathways so your body can get rid of waste [1][2].
Commonly used scavengers include:
- Sodium Benzoate: A traditional medication used for both daily management and emergencies [8][9].
- Phenylbutyrate (Sodium or Glycerol): These are often used for long-term control. Glycerol phenylbutyrate is a liquid version that some patients find easier to tolerate [10][2].
Scavenger Precautions: Scavengers must be carefully dosed by weight. They carry a heavy sodium load and often have gastrointestinal or taste burdens. Never stop them without contacting your metabolic team.
Long-Term Monitoring
Because your needs change as you grow, get sick, or change your activity level, you will need regular “tune-ups” with your metabolic team. Routine monitoring typically includes:
- Ammonia and Amino Acids: Checking your blood levels to ensure your protein-to-energy balance is correct [1][5].
- Growth Tracking: Monitoring height and weight “z-scores” (growth percentiles) to ensure the diet isn’t too restrictive [5].
- Liver Health: Regular blood tests for liver enzymes (ALT/AST) and clotting factors to watch for signs of liver stress [11][12].
- Sick-Day Planning: Every patient must have a written “Emergency Protocol” for times of illness, which often involves a clinician-directed, time-limited reduction of natural protein and increasing calorie-rich, protein-free drinks [3][8]. If vomiting or inability to drink occurs, you must escalate to emergency care immediately.
Common questions in this guide
What kind of diet is used to manage HHH syndrome?
Why are enough calories important in HHH syndrome?
Are L-citrulline and L-arginine interchangeable for HHH syndrome?
Why might lysine or branched-chain amino acids be prescribed?
When are ammonia-scavenger medicines used in HHH syndrome?
What should I do if someone with HHH syndrome becomes ill or vomits?
What monitoring is needed for HHH syndrome?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Diet and protein
Could I work with a metabolic dietitian to find out how much natural protein I can eat?
Ongoing lab checks
How does my team check that my protein and energy intake are balanced?
Medication options
Which ammonia scavenger medicines would my team consider, and why?
Get notified when new evidence is published on Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (12)
- 1
The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
Martinelli D, Diodato D, Ponzi E, et al.
Orphanet journal of rare diseases 2015; (10()):29 doi:10.1186/s13023-015-0242-9.
PMID: 25874378 - 2
Urea cycle defects in adulthood: clinical presentation, diagnosis and treatment in genetically encoded hepatic metabolic disorders with a potential for encephalopathy.
Das AM
Metabolic brain disease 2025; (40(5)):192 doi:10.1007/s11011-025-01619-5.
PMID: 40285952 - 3
Immune Alterations in a Patient With Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome: A Case Report.
Silvera-Ruiz SM, Gemperle C, Peano N, et al.
Frontiers in immunology 2022; (13()):861516 doi:10.3389/fimmu.2022.861516.
PMID: 35711415 - 4
Role of early management of hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome in pregnancy.
Billingham MJ, Rizk R
BMJ case reports 2021; (14(7)) doi:10.1136/bcr-2020-241424.
PMID: 34210698 - 5
Decreased plasma l-arginine levels in organic acidurias (MMA and PA) and decreased plasma branched-chain amino acid levels in urea cycle disorders as a potential cause of growth retardation: Options for treatment.
Molema F, Gleich F, Burgard P, et al.
Molecular genetics and metabolism 2019; (126(4)):397-405 doi:10.1016/j.ymgme.2019.02.003.
PMID: 30827756 - 6
Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea-cycle disorders: On the basis of information from a European multicenter registry.
Molema F, Gleich F, Burgard P, et al.
Journal of inherited metabolic disease 2019; (42(6)):1162-1175 doi:10.1002/jimd.12066.
PMID: 30734935 - 7
Hyperornithinemia, Hyperammonemia, and Homocitrullinuria Syndrome Causing Severe Neonatal Hyperammonemia.
Wild KT, Ganetzky RD, Yudkoff M, Ierardi-Curto L
JIMD reports 2019; (44()):103-107 doi:10.1007/8904_2018_132.
PMID: 30187369 - 8
Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study.
Husson MC, Schiff M, Fouilhoux A, et al.
Orphanet journal of rare diseases 2016; (11(1)):127 doi:10.1186/s13023-016-0513-0.
PMID: 27663197 - 9
Successful liver transplantation in hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: Case report.
De Bruyne P, Verloo P, Van Hove JLK, et al.
Pediatric transplantation 2021; (25(6)):e13943 doi:10.1111/petr.13943.
PMID: 33314525 - 10
Biochemical testing and pathology reveal rare cause of pediatric acute liver failure: Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
Mosher TL, Czepiel KS, Neu MB, et al.
JPGN reports 2026; doi:10.1002/jpr3.70206.
PMID: 42516736 - 11
Chronic liver involvement in urea cycle disorders.
Ranucci G, Rigoldi M, Cotugno G, et al.
Journal of inherited metabolic disease 2019; (42(6)):1118-1127 doi:10.1002/jimd.12144.
PMID: 31260111 - 12
Hyperornithinemia-Hyperammonemia-Homocitrullinuria Syndrome in Vietnamese Patients.
Nguyen KN, Tran VK, Nguyen NL, et al.
Medicina (Kaunas, Lithuania) 2024; (60(11)) doi:10.3390/medicina60111877.
PMID: 39597062
This page is for informational purposes only and does not constitute medical advice. Your metabolic team must set your protein, supplement, scavenger, and ammonia targets and guide any treatment changes.